Author

Burcu Temizoz

Institute of Medical Science, The University of TokyoORCID 0000-0002-5189-3529Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Christopher SchlieheiD· 1 shared Eric M. BindelsiD· 1 shared Harmen J.G. van de WerkeniD· 1 shared Inge Brouwers-HaspelsiD· 1 shared Ken J. IshiiiD· 1 shared Kou HiokiiD· 1 shared Marjan van MeursiD· 1 shared Marlous WildemansiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Christopher SchlieheORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Prime-Target neoantigen vaccination unleashes unprecedented T cell immunity within ''cold'' immunosuppressive tumors

Kou Hioki, Marlous Wildemans, Youkyung Lim, Inge Brouwers-Haspels, Marjan van Meurs, Eric M. Bindels, Harmen J.G. van de Werken, Yvonne M. Mueller, Burcu Temizoz, Ken J. Ishii, Christopher Schliehe, Peter D. Katsikis

This study demonstrates that Prime-Target neoantigen vaccination effectively overcomes immunosuppression in 'cold' tumors by enhancing T cell infiltration and reshaping the tumor microenvironment.

bioRxiv · Jan 13, 2026 · PreprintImmunology